Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.12

November 8, 2012 5:33 PM EST Send to a Friend
Get Alerts NABI Hot Sheet
Trade NABI Now!
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q3 EPS of ($0.12), versus ($0.07) reported last year. Revenue for the quarter came in at $632 thousand, versus $1.1 million reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment